Skip to main content
Premium Trial:

Request an Annual Quote

Axygen Scientific Launches New Business Unit to Focus on Genomics, Proteomics Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Axygen Scientific has created a new subdivision called Axygen Bioscience that focuses on genomics, proteomics, and protein crystallography.


The company decided to create the new division in order to expand into the area of proteomics, which executives identified as one of the key areas for pharmaceutical companies, Arezou Arazani, director of new product and business development at Axygen Bioscience, told GenomeWeb News.


"They brought me into the company and said they wanted to get into new technology," said Arazani. "I said the future is in proteomics. Most pharma companies have genetic information from humans and other species, but they need the protein for more information. The new technology covers all the area from DNA to protein crystallography."


Based in Union City, Calif., Axygen Bioscience has over 400 employees, 100 of whom were new hires and 50 of whom are scientists, said Arazani.


Products produced by the new division include nucleic acid and peptide purification kits, markers, crystallography plates, sealers, reagents, software, databases, and high-throughput laboratory robotics and automation platforms.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.